Fundraising Fox

Luc Dochez

Investor

Managing Partner at Droia Ventures

Seattle, Washington, United States

ContactΒ· self-published, not guessed

Experience

  1. Primix BioventuresManaging Directorcurrent2001 β€” present
  2. DROIA Oncology VenturesPartnercurrent2018 β€” present
  3. Montis BiosciencesCo-Founder and Executive Chairmancurrent2019 β€” present
  4. Vico Therapeutics BVFounder and Managing Directorcurrent2019 β€” present
  5. ERYTECH PharmaBoard Membercurrent2015 β€” present
  6. Pharvaris B.V.Co-Founder and Board member2016 β€” 2019
  7. Tusk Therapeutics NVCEO2015 β€” 2018
  8. Prosensa Therapeutics BVSenior Vice-President Business Development and Chief Business Officer2008 β€” 2015
  9. TiGenix NVVP Business Development2003 β€” 2008
  10. Arthur D. LittleConsultant1999 β€” 2001Brussels Area, Belgium

Skills & more

Biopharmaceuticals25Biotechnology41Business Development35Life Sciences13Lifesciences20Mergers3Oncology8Start-ups10Venture Capital5Business Strategy5Pharmaceutical Industry25Strategy8

From Luc's professional profile.

Deals Β· 2

QuralisBoard seat

via Droia Ventures Β· filed Sep 2025 Β· $24.9M raise

Summation BioBoard seat

via Droia Ventures Β· filed Apr 2022 Β· $64.5M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Droia Ventures

Frequently asked questions

Who is Luc Dochez?
Managing Partner at Droia Ventures
Where does Luc Dochez work?
Luc Dochez is Managing Partner at Droia Ventures.
What boards does Luc Dochez sit on?
Luc Dochez holds tracked board seats at Quralis, Summation Bio.
Where did Luc Dochez go to school?
Luc Dochez studied at KU Leuven (Master of Science - MS, Farmaceutische wetenschappen); Vlerick Business School (Master of Business Administration (MBA)).

Same school

Shared employers